Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients

Clinical trial NCT01929408 · COMPLETED

Trial details

NCT number: NCT01929408
Sponsor: Fred Hutchinson Cancer Center
Status: COMPLETED
Study type: OBSERVATIONAL

Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)

Start date: 2013-07-19
Primary completion: 2018-12-04
Enrollment: 703

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.